Trial record 23 of 31 for: "Preeclampsia/eclampsia 1" | "Antihypertensive Agents"
ToRsemide for pOstpartum HYpertension (TROPHY)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02813551|
Recruitment Status : Completed
First Posted : June 27, 2016
Results First Posted : April 10, 2019
Last Update Posted : April 10, 2019
The University of Texas Health Science Center, Houston
Information provided by (Responsible Party):
Oscar Andres Viteri Molina, The University of Texas Health Science Center, Houston
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor); Primary Purpose: Prevention|
Median hospital stay <3 days, but sample size powered to detect differences in up to 5 days. High rate of clinic no-shows. Not powered to detect differences in secondary outcomes. Edema measurements done with stocking, which may affect reliability.